Association between CHFR methylation and chemosensitivity of paclitaxel in advanced gastric cancer
- 18 March 2014
- journal article
- Published by Springer Nature in Medical Oncology
- Vol. 31 (4) , 1-2
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicineCancer and Metastasis Reviews, 2013
- The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancerJournal of Gastroenterology, 2006
- DNA methylation of CHFR is not a predictor of the response to docetaxel and paclitaxel in advanced and recurrent gastric cancer.2006